Rousselot, a leader in collagen and gelatin innovation, has launched Nextida, a groundbreaking platform of collagen peptide compositions designed to target specific health benefits. Backed by rigorous scientific research, Nextida aims to transform natural health and wellness products through a deep understanding of collagen’s properties. Nextida’s library of collagen peptide compositions has been meticulously validated through preclinical and clinical trials. This research ensures the efficacy and safety of these peptides, offering targeted health benefits beyond traditional formulations. The first commercialized product, Nextida.GC, aims to reduce post-meal sugar spikes naturally, with promising results to be unveiled at the SupplySide West event.
Gaëtan Noiret, Rousselot’s global director of health and nutrition, emphasizes that Nextida represents a new era of innovation, unlocking health benefits previously unknown for collagen peptides, particularly in preventative health. The platform supports the development of high-quality nutraceutical ingredients tailored to modern consumer trends, heralding a significant advancement in natural health solutions.
Home » Nextida: Pioneering a New Frontier in Collagen Peptide Innovation
Nextida: Pioneering a New Frontier in Collagen Peptide Innovation
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Dietary Zinc Could Lower Endometriosis Risk
November 2, 2024
Grape Seed Extract for Mood Regulation and Cognitive Health
October 24, 2024
Menthol : A Novel Therapeutic Pathway for Alzheimer’s
October 24, 2024
Vitamin D and Probiotics: A New Strategy for Managing Migraines
October 18, 2024
Spermidine: The Polyamine with Potential for a Healthier Heart!
October 18, 2024